Antithrombotic Therapy After LAAO: Changes in Care - 2023 Quality Summit Presentation (Non-CE)-Antithrombotic Therapy After LAAO: Changes in Care

Video Transcription

Video Summary

In this video, Dr. Abhijit Doble discusses the changes in antithrombotic therapy after left atrial appendage occlusion (LAO). He explains that the primary devices used for LAO are the Watchman and Amulet, and he describes the differences between the two. He discusses the evolution of antithrombotic therapy after LAO and highlights the changes in medication regimen for both devices. He emphasizes the importance of post-implant imaging to evaluate for device-related thrombus and peri-device leak. He also discusses the use of oral anticoagulants and antiplatelet agents based on patient characteristics. Dr. Doble provides recommendations for prescription writing, patient communication, and follow-up monitoring. He emphasizes the need for ongoing communication with referring providers and the importance of maintaining adherence to the recommended medication regimen. He also discusses the NCDR LAO Registry and the data that should be submitted for the first four visits post-LAO. Overall, Dr. Doble provides a comprehensive overview of the changes in antithrombotic therapy after LAO and the importance of appropriate medication management and follow-up monitoring.

Keywords

antithrombotic therapy

left atrial appendage occlusion

Watchman

Amulet

medication regimen

post-implant imaging

oral anticoagulants

antiplatelet agents

follow-up monitoring